There are some key discussions that men with metastatic prostate cancer should have with their health care providers.
Jan Manarite, executive vice president of Prostate Cancer International, discusses what a man with prostate cancer should do when his disease is progressing and his PSA levels are rising while on hormone therapy.
It is important that men in this situation know their PSA levels, as well as their PSA doubling time. Then, the metastases themselves will be found via medical imaging. Since no medical imaging tool is perfect, patients and their loved ones should have conversations with their health care teams about how accurate the selected imaging method is when it comes to looking for prostate cancer metastases.
Novel Drug Granted FDA Fast Track in Rare Prostate Cancer Subset
February 13th 2024The Food and Drug Administration has granted a Fast Track designation to the novel immune activator drug BXCL701 in combination with a checkpoint inhibitor for patients with metastatic small cell neuroendocrine prostate cancer (SCNC).
Read More